Tactile Systems Technology, Inc. (TCMD) Stock Score, Valuation & Financial Research

Tactile Systems Technology, Inc. is in the Healthcare sector and Medical - Devices industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 48/100.

Quick answer for TCMD

Tactile Systems Technology, Inc. currently has a Wall Street Score of 48/100. The stored market price is $22.32. Its financial score is 36/100. Its valuation score is 27/100. These figures are a research snapshot, not a buy or sell recommendation.

What Tactile Systems Technology, Inc. does

Tactile Systems Technology, Inc. is a medical technology firm that develops and supplies specialized devices to treat chronic health conditions across the United States. Its product portfolio features the Flexitouch Plus system, a pneumatic compression device designed for managing lymphedema. The company also offers the Entre system, a portable pneumatic compression solution for at-home treatment of various venous disorders, including lymphedema, chronic venous insufficiency, and venous leg ulcers. Additionally, Tactile Systems provides the AffloVest, a portable high-frequency chest wall oscillation device used to address retained pulmonary secretions associated with conditions such as bronchiectasis, cystic fibrosis, and certain neuromuscular disorders. Established in 1995, the company maintains its headquarters in Minneapolis, Minnesota.

TCMD financial snapshot

Wall Street Score:
48/100
Current price:
$22.32
Market capitalization:
$503.5M
Revenue:
$343.5M
Net income:
$20.3M
Free cash flow:
$40.4M
Cash:
$75.0M
Total debt:
$15.2M
EPS:
0.83
P/E ratio:
26.9x
Financial score:
36/100
Valuation score:
27/100
Revenue score:
23/100

What stands out

  • Reported year-over-year revenue growth is +0.0%.
  • Free cash flow is $40.4M, showing positive cash generation.
  • The balance sheet shows $75.0M of cash versus $15.2M of total debt, leaving more cash than debt.

What the numbers mean

Its current valuation score is 27/100, which Wall Street Score classifies as weak within the model's valuation framework.

The financial score is 36/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.

A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.

Data freshness: Financial data last refreshed 2026-07-24.

How to research TCMD

Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.

Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks

Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.